首页 > 最新文献

Physiological reviews最新文献

英文 中文
Unlocking the potential of circadian biology for cardiovascular health. 释放心血管健康的昼夜节律生物学潜力。
IF 28.7 1区 医学 Q1 PHYSIOLOGY Pub Date : 2026-07-01 Epub Date: 2026-01-07 DOI: 10.1152/physrev.00015.2025
Steven A Shea, Frank A J L Scheer, Michelle L Gumz, Sophia A Eikenberry, Jingyi Qian, Saurabh S Thosar, Michael J Sole, Tami A Martino

Circadian rhythms, governed by the body's endogenous clock mechanism, regulate daily fluctuations in cardiovascular function, optimizing physiological processes like blood pressure regulation, cardiac metabolism, and myocardial repair. Rhythms also align cardiovascular reactivity with predictable environmental and behavioral cycles, enabling normal function and affecting disease susceptibility. Major adverse cardiovascular events, including myocardial infarction, ventricular arrhythmias, and stroke, exhibit a distinct morning peak, with evidence for circadian regulation in cardiovascular health. Indeed, controlled human laboratory studies demonstrate that beyond the influences of sleep and other behaviors, endogenous circadian rhythms independently regulate blood pressure, autonomic nervous system activity, blood clotting, vascular tone, and metabolic function. Additionally, the kidney plays a critical role in circadian sodium handling, fluid balance, and blood pressure control, with disruptions in renal circadian rhythms contributing to hypertension and progression to heart failure. Chronic circadian misalignment resulting from shift work, irregular sleep-wake cycles, or misaligned lifestyle habits is strongly associated with increased cardiovascular risk and disease progression. The emerging field of Circadian Medicine applies circadian principles to clinical care, leveraging interventions such as optimizing light exposure, meal timing, and physical activity to restore biological alignment. Chronotherapy, the strategic timing of medications or procedures to align with a patient's diurnal or circadian rhythms, offers further potential for enhancing treatments and reducing adverse effects. By integrating circadian biology into cardiovascular medicine, novel strategies are emerging to help prevent disease, improve patient outcomes, and enhance therapeutic precision. Understanding the interplay between circadian regulation and cardiovascular physiology provides a foundation for advancing cardiovascular prevention and treatment strategies.

昼夜节律受人体内源性时钟机制支配,调节心血管功能的日常波动,优化血压调节、心脏代谢和心肌修复等生理过程。节律还使心血管反应与可预测的环境和行为周期相一致,使功能正常并影响疾病易感性。主要的不良心血管事件,包括心肌梗死、室性心律失常和中风,都表现出明显的早晨高峰,突出了心血管健康的昼夜节律调节。受控的人体实验室研究表明,除了睡眠和其他行为的影响外,内源性昼夜节律还独立调节血压、自主神经系统活动、血液凝固、血管张力和代谢功能。此外,肾脏在昼夜钠处理、体液平衡和血压控制中起着至关重要的作用,肾脏昼夜节律的紊乱会导致高血压和心力衰竭。轮班工作、不规律的睡眠-觉醒周期或不一致的生活习惯导致的慢性昼夜节律失调与心血管风险增加和疾病进展密切相关。昼夜节律医学这一新兴领域将昼夜节律原理应用于临床护理,利用诸如优化光照、进餐时间和身体活动等干预措施来恢复生物一致性。时间疗法,即根据患者的昼夜或昼夜节律对药物或程序进行策略性定时治疗,为加强治疗和减少不良反应提供了进一步的潜力。通过将昼夜节律生物学整合到心血管医学中,新的策略正在出现,以帮助预防疾病,改善患者预后,提高治疗精度。了解昼夜节律调节与心血管生理之间的相互作用为推进心血管预防和治疗策略提供了基础。
{"title":"Unlocking the potential of circadian biology for cardiovascular health.","authors":"Steven A Shea, Frank A J L Scheer, Michelle L Gumz, Sophia A Eikenberry, Jingyi Qian, Saurabh S Thosar, Michael J Sole, Tami A Martino","doi":"10.1152/physrev.00015.2025","DOIUrl":"10.1152/physrev.00015.2025","url":null,"abstract":"<p><p>Circadian rhythms, governed by the body's endogenous clock mechanism, regulate daily fluctuations in cardiovascular function, optimizing physiological processes like blood pressure regulation, cardiac metabolism, and myocardial repair. Rhythms also align cardiovascular reactivity with predictable environmental and behavioral cycles, enabling normal function and affecting disease susceptibility. Major adverse cardiovascular events, including myocardial infarction, ventricular arrhythmias, and stroke, exhibit a distinct morning peak, with evidence for circadian regulation in cardiovascular health. Indeed, controlled human laboratory studies demonstrate that beyond the influences of sleep and other behaviors, endogenous circadian rhythms independently regulate blood pressure, autonomic nervous system activity, blood clotting, vascular tone, and metabolic function. Additionally, the kidney plays a critical role in circadian sodium handling, fluid balance, and blood pressure control, with disruptions in renal circadian rhythms contributing to hypertension and progression to heart failure. Chronic circadian misalignment resulting from shift work, irregular sleep-wake cycles, or misaligned lifestyle habits is strongly associated with increased cardiovascular risk and disease progression. The emerging field of Circadian Medicine applies circadian principles to clinical care, leveraging interventions such as optimizing light exposure, meal timing, and physical activity to restore biological alignment. Chronotherapy, the strategic timing of medications or procedures to align with a patient's diurnal or circadian rhythms, offers further potential for enhancing treatments and reducing adverse effects. By integrating circadian biology into cardiovascular medicine, novel strategies are emerging to help prevent disease, improve patient outcomes, and enhance therapeutic precision. Understanding the interplay between circadian regulation and cardiovascular physiology provides a foundation for advancing cardiovascular prevention and treatment strategies.</p>","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":" ","pages":"1195-1262"},"PeriodicalIF":28.7,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12882775/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The alpha rhythm: from physiology to behavior. 阿尔法节奏:从生理到行为。
IF 28.7 1区 医学 Q1 PHYSIOLOGY Pub Date : 2026-07-01 Epub Date: 2026-02-03 DOI: 10.1152/physrev.00001.2025
Ole Jensen, Mathilde Bonnefond

The alpha rhythm, first identified by Hans Berger 100 years ago, is the dominant noninvasive electrophysiological signature of the healthy human brain in the awake state. For decades, it was believed that the alpha rhythm reflected rest or idling; however, this perspective changed in the 2000s when researchers found that alpha oscillations increase with cognitive demands. This discovery led to a paradigm shift, demonstrating that alpha oscillations reflect the functional inhibition of brain regions that are not needed for a specific task, thereby directing information to task-specific areas. We have reviewed the physiological mechanisms involved in generating alpha oscillations, which have informed computational models explaining how these oscillations emerge within physiologically realistic networks. At the behavioral level, alpha oscillations are strongly modulated across nearly all cognitive paradigms tested in humans, reflecting the allocation of computational resources within the active brain network. Research in individuals with attention-related issues has highlighted their impaired ability to modulate alpha oscillations, which is associated with performance deficits. Therefore, further exploration of alpha oscillations has the potential to uncover causal mechanisms underlying attention problems, such as those related to attention deficit hyperactivity disorder (ADHD) and aging. Finally, advancements in technology are opening new avenues for characterizing alpha oscillations in ecologically valid settings and across the lifespan. This progress sets the stage for exploring the role of alpha oscillations in cognitive development and their functioning in natural environments.

100年前,汉斯·伯杰(Hans Berger)首次发现了α节律,它是健康人脑在清醒状态下的主要非侵入性电生理特征。几十年来,人们认为阿尔法节律反映了休息或空闲;然而,这种观点在2000年代发生了变化,当时研究人员发现α振荡随着认知需求的增加而增加。这一发现导致了范式的转变,表明α振荡反映了特定任务不需要的大脑区域的功能抑制,从而将信息引导到特定任务的区域。我们回顾了产生α振荡的生理机制,这为解释这些振荡如何在生理现实网络中出现的计算模型提供了信息。在行为层面,α振荡在几乎所有的人类认知范式中都被强烈调节,反映了活跃的大脑网络中计算资源的分配。对有注意力相关问题的个体的研究强调了他们调节α振荡的能力受损,这与表现缺陷有关。因此,对α振荡的进一步探索有可能揭示注意力问题的因果机制,例如与ADHD和衰老相关的问题。最后,技术的进步为在生态有效的环境和整个生命周期中表征α振荡开辟了新的途径。这一进展为探索α振荡在认知发展中的作用及其在自然环境中的功能奠定了基础。
{"title":"The alpha rhythm: from physiology to behavior.","authors":"Ole Jensen, Mathilde Bonnefond","doi":"10.1152/physrev.00001.2025","DOIUrl":"10.1152/physrev.00001.2025","url":null,"abstract":"<p><p>The alpha rhythm, first identified by Hans Berger 100 years ago, is the dominant noninvasive electrophysiological signature of the healthy human brain in the awake state. For decades, it was believed that the alpha rhythm reflected rest or idling; however, this perspective changed in the 2000s when researchers found that alpha oscillations increase with cognitive demands. This discovery led to a paradigm shift, demonstrating that alpha oscillations reflect the functional inhibition of brain regions that are not needed for a specific task, thereby directing information to task-specific areas. We have reviewed the physiological mechanisms involved in generating alpha oscillations, which have informed computational models explaining how these oscillations emerge within physiologically realistic networks. At the behavioral level, alpha oscillations are strongly modulated across nearly all cognitive paradigms tested in humans, reflecting the allocation of computational resources within the active brain network. Research in individuals with attention-related issues has highlighted their impaired ability to modulate alpha oscillations, which is associated with performance deficits. Therefore, further exploration of alpha oscillations has the potential to uncover causal mechanisms underlying attention problems, such as those related to attention deficit hyperactivity disorder (ADHD) and aging. Finally, advancements in technology are opening new avenues for characterizing alpha oscillations in ecologically valid settings and across the lifespan. This progress sets the stage for exploring the role of alpha oscillations in cognitive development and their functioning in natural environments.</p>","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":" ","pages":"1123-1159"},"PeriodicalIF":28.7,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7618721/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146113941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond. 用于癌症治疗的抗体-药物偶联物设计和作用机制:最新进展及展望。
IF 33.6 1区 医学 Q1 PHYSIOLOGY Pub Date : 2026-03-19 DOI: 10.1152/physrev.00039.2025
Anthony Cheung,Yi Liu,Alicia M Chenoweth,Hanieh Montaseri,Benjamina Esapa,Vijay Chudasama,James R Baker,David E Thurston,Sophia N Karagiannis
Antibody-drug conjugates (ADCs) are a leading area of targeted cancer therapeutics, typically combining a tumour-associated antigen-specific antibody conjugated to a toxic payload that targets key cellular mechanisms, such as mitosis and survival. The global ADC clinical trial landscape has been expanding significantly, with over 430 ADCs reaching early to late clinical studies in the past two decades, up from just 90 between 2004 and 2014. The US Food and Drug Administration (FDA) has so far approved 14 ADCs for use in clinical oncology. This growth is likely driven by significant advances in antibody technology and conjugation methods enabling more effective and precise delivery to cancer cells and more effective payloads that target vital cancer biology. Here, we review the ADCs that have reached clinical approval as well as current and emerging trends in ADC development, and we discuss these from multiple perspectives, including ADC mechanisms of action, emerging antigen targets, linker and conjugation chemistry, payloads, combination of ADC with checkpoint inhibitor immunotherapy and antibody Fc-engineering. We also consider how the field is evolving through the application of artificial intelligence (AI) and pathology-based biomarker discovery. Combined, innovative and emerging ADC design coupled with precision medicine and patient stratification strategies hold great promise to develop diverse and personalised cancer treatments with improved therapeutic indices, and to enhance tolerability compared to traditional chemotherapy and current established ADCs. This review aims to assist researchers in exploring the evolution, characteristics, and development trends in ADC design and to provide new directions for future research.
抗体-药物偶联物(adc)是靶向癌症治疗的一个领先领域,通常将肿瘤相关抗原特异性抗体偶联到针对关键细胞机制(如有丝分裂和存活)的有毒有效载荷。全球ADC临床试验领域一直在显著扩大,在过去20年里,超过430种ADC进入了早期到晚期的临床研究,而2004年至2014年期间只有90种。迄今为止,美国食品和药物管理局(FDA)已批准14种adc用于临床肿瘤学。这种增长可能是由抗体技术和偶联方法的重大进步推动的,这些技术和偶联方法能够更有效、更精确地递送到癌细胞,以及更有效地靶向重要癌症生物学的有效载荷。在这里,我们回顾了已获得临床批准的ADC以及ADC发展的当前和新兴趋势,并从多个角度进行了讨论,包括ADC的作用机制、新出现的抗原靶点、连接物和偶联化学、有效载荷、ADC与检查点抑制剂免疫治疗的联合以及抗体fc工程。我们还考虑了该领域如何通过应用人工智能(AI)和基于病理的生物标志物发现而发展。与传统化疗和现有ADC相比,创新和新兴ADC设计与精准医学和患者分层策略相结合,有望开发出多样化和个性化的癌症治疗方法,改善治疗指标,并提高耐受性。本文旨在帮助研究人员了解ADC设计的演变、特点和发展趋势,并为未来的研究提供新的方向。
{"title":"Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond.","authors":"Anthony Cheung,Yi Liu,Alicia M Chenoweth,Hanieh Montaseri,Benjamina Esapa,Vijay Chudasama,James R Baker,David E Thurston,Sophia N Karagiannis","doi":"10.1152/physrev.00039.2025","DOIUrl":"https://doi.org/10.1152/physrev.00039.2025","url":null,"abstract":"Antibody-drug conjugates (ADCs) are a leading area of targeted cancer therapeutics, typically combining a tumour-associated antigen-specific antibody conjugated to a toxic payload that targets key cellular mechanisms, such as mitosis and survival. The global ADC clinical trial landscape has been expanding significantly, with over 430 ADCs reaching early to late clinical studies in the past two decades, up from just 90 between 2004 and 2014. The US Food and Drug Administration (FDA) has so far approved 14 ADCs for use in clinical oncology. This growth is likely driven by significant advances in antibody technology and conjugation methods enabling more effective and precise delivery to cancer cells and more effective payloads that target vital cancer biology. Here, we review the ADCs that have reached clinical approval as well as current and emerging trends in ADC development, and we discuss these from multiple perspectives, including ADC mechanisms of action, emerging antigen targets, linker and conjugation chemistry, payloads, combination of ADC with checkpoint inhibitor immunotherapy and antibody Fc-engineering. We also consider how the field is evolving through the application of artificial intelligence (AI) and pathology-based biomarker discovery. Combined, innovative and emerging ADC design coupled with precision medicine and patient stratification strategies hold great promise to develop diverse and personalised cancer treatments with improved therapeutic indices, and to enhance tolerability compared to traditional chemotherapy and current established ADCs. This review aims to assist researchers in exploring the evolution, characteristics, and development trends in ADC design and to provide new directions for future research.","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":"9 1","pages":""},"PeriodicalIF":33.6,"publicationDate":"2026-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147483332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Lethal Symbiont: Exploring the Pathophysiology of Cancer. 致命的共生体:探索癌症的病理生理学。
IF 28.7 1区 医学 Q1 PHYSIOLOGY Pub Date : 2026-03-12 DOI: 10.1152/physrev.00019.2025
Emma Nolan, Leanne Li, Evangelos Giampazolias, Luigi Ombrato, Ilaria Malanchi

From its early genesis, cancer is integrated with the surrounding tissue. Its very existence depends on surrounding normal tissue cells engaging with cancer cells to create an alternative tissue environment. This emerging abnormal structure becomes connected with the host organism via blood, lymphatic vessels, and neural connections. Through those connections, the cancer mass communicates and perturbs the entire organism altering various aspects of the steady state body physiology. At early, asymptomatic stages, the induced changes within distant organs that harbour the potential to facilitate the spread of cancer are termed "premetastatic niche". Many processes involved with pre-metastatic changes hijack processes typical in other context such as development, injury, or infections, but their co-occurrence creates a new alternative physiology. The cancer to body connections not only have important consequences for the efficacy of cancer therapy but enable cancer to evolve and adapt under the very pressure of those treatments. Furthermore, as cancer induced changes are closely related to other physiological challenges, extrinsic perturbations such as diet, injury, and other inflammatory events, have strong impact on the tumour disease. As the disease progresses, the complex intersection of inflammatory, metabolic, regenerative changes creates an escalating cascade of events causing cancer related syndrome, such as cachexia, that threaten the homeostasis of the entire body and can, per se, be deadly. In this article we will review the recent advances in the understanding of cancer as systemic malady.

从早期发生开始,癌症就与周围组织结合在一起。它的存在依赖于周围的正常组织细胞与癌细胞结合,创造一个替代的组织环境。这种新出现的异常结构通过血液、淋巴管和神经连接与宿主生物联系在一起。通过这些联系,肿瘤团块交流并扰乱整个生物体,改变稳态身体生理的各个方面。在早期无症状阶段,在远处器官内诱发的有可能促进癌症扩散的变化被称为“转移前生态位”。许多与转移前变化有关的过程劫持了其他情况下的典型过程,如发育、损伤或感染,但它们的共同发生创造了一种新的替代生理学。癌症与身体的联系不仅对癌症治疗的疗效有重要影响,而且使癌症能够在这些治疗的压力下进化和适应。此外,由于癌症引起的变化与其他生理挑战密切相关,饮食、损伤和其他炎症事件等外在扰动对肿瘤疾病有很强的影响。随着疾病的发展,炎症、代谢、再生变化的复杂交叉产生了不断升级的级联事件,导致癌症相关综合征,如恶病质,威胁到整个身体的内稳态,本身就是致命的。在这篇文章中,我们将回顾癌症作为全身性疾病的认识的最新进展。
{"title":"The Lethal Symbiont: Exploring the Pathophysiology of Cancer.","authors":"Emma Nolan, Leanne Li, Evangelos Giampazolias, Luigi Ombrato, Ilaria Malanchi","doi":"10.1152/physrev.00019.2025","DOIUrl":"https://doi.org/10.1152/physrev.00019.2025","url":null,"abstract":"<p><p>From its early genesis, cancer is integrated with the surrounding tissue. Its very existence depends on surrounding normal tissue cells engaging with cancer cells to create an alternative tissue environment. This emerging abnormal structure becomes connected with the host organism via blood, lymphatic vessels, and neural connections. Through those connections, the cancer mass communicates and perturbs the entire organism altering various aspects of the steady state body physiology. At early, asymptomatic stages, the induced changes within distant organs that harbour the potential to facilitate the spread of cancer are termed \"premetastatic niche\". Many processes involved with pre-metastatic changes hijack processes typical in other context such as development, injury, or infections, but their co-occurrence creates a new alternative physiology. The cancer to body connections not only have important consequences for the efficacy of cancer therapy but enable cancer to evolve and adapt under the very pressure of those treatments. Furthermore, as cancer induced changes are closely related to other physiological challenges, extrinsic perturbations such as diet, injury, and other inflammatory events, have strong impact on the tumour disease. As the disease progresses, the complex intersection of inflammatory, metabolic, regenerative changes creates an escalating cascade of events causing cancer related syndrome, such as cachexia, that threaten the homeostasis of the entire body and can, per se, be deadly. In this article we will review the recent advances in the understanding of cancer as systemic malady.</p>","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":" ","pages":""},"PeriodicalIF":28.7,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147435002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physiology of oligodendroglia. 少突胶质细胞生理学。
IF 28.7 1区 医学 Q1 PHYSIOLOGY Pub Date : 2026-03-06 DOI: 10.1152/physrev.00023.2025
Arthur M Butt, Jianqin Niu, Chenju Yi, Alexei Verkhratsky

Oligodendrocytes are highly specialized neural cells that produce myelin, essential for rapid electrical conduction of neural signals in the central nervous system (CNS). The emergence of oligodendrocytes and myelin was a critical step in the evolution of vertebrates and fundamental for the development of the mammalian connectome, and indispensable for miniaturization and enhanced computing power of the brain. The advance in cognitive capacity is paralleled by increasing eminence of white matter, composed of interconnected bundles of myelinated axons; white matter volume increases from 6% of the brain in shrews, considered related to the most primitive mammals, up to 50% in Homo sapiens. Myelinating oligodendrocytes together with smaller populations of oligodendrocyte precursor cells (OPCs) and satellite or perineuronal oligodendrocytes account for more than half the glial cells in the human brain. Together, these three cell types make up the oligodendroglial cell lineage that express common lineage specific proteins and transcription factors and display a degree of molecular and functional diversity. OPCs are the most numerous oligodendroglial cells during developmental axonal myelination, which extends postnatally for many years in humans. The generation of myelinating oligodendrocytes from OPCs throughout life continues to be important for adaptive plasticity of neural circuits and myelination of new axons required for learning. Myelination decreases in the aging brain and correlates with natural or physiological age-related cognitive decline. Like all neural cells, oligodendroglia express a wide assortment of ion channels, transporters, and neurotransmitter receptors that are essential for maintaining neuronal signaling, principally myelination, axonal metabolic support and homeostatic regulation of the periaxonal microenvironment. Notably, OPCs are unique amongst neuroglia in that, like neurons, they are electrically excitable and form synapses with neurons. Oligodendroglial cells also contribute to neuroplasticity through multiple mechanisms including axon guidance, synapse formation and adaptive myelination. In short, oligodendroglia are essential for normal CNS integrity, cognitive function and behavior.

少突胶质细胞是高度特化的神经细胞,可产生髓磷脂,髓磷脂对中枢神经系统(CNS)神经信号的快速电传导至关重要。少突胶质细胞和髓磷脂的出现是脊椎动物进化的关键一步,也是哺乳动物连接体发育的基础,对大脑的小型化和增强计算能力必不可少。认知能力的提高与白质的增加是平行的,白质是由相互连接的髓鞘轴突束组成的;大脑白质的体积从鼩鼱的6%(被认为与最原始的哺乳动物有关)增加到智人的50%。髓鞘性少突胶质细胞与较少的少突胶质前体细胞(OPCs)和卫星细胞或神经元周围少突胶质细胞一起占人脑胶质细胞的一半以上。总之,这三种细胞类型构成了少突胶质细胞谱系,表达共同谱系特异性蛋白质和转录因子,并显示一定程度的分子和功能多样性。OPCs是发育性轴突髓鞘形成过程中数量最多的少突胶质细胞,其在人类出生后可延续多年。在整个生命过程中,OPCs的髓鞘化少突胶质细胞的产生对于神经回路的适应性可塑性和学习所需的新轴突的髓鞘化仍然是重要的。髓鞘形成在衰老的大脑中减少,与自然或生理年龄相关的认知能力下降有关。像所有的神经细胞一样,少突胶质细胞表达各种各样的离子通道、转运体和神经递质受体,这些对于维持神经元信号传导至关重要,主要是髓鞘形成、轴突代谢支持和轴突周围微环境的稳态调节。值得注意的是,OPCs在神经胶质中是独一无二的,就像神经元一样,它们是可电兴奋的,并与神经元形成突触。少突胶质细胞还通过多种机制促进神经可塑性,包括轴突引导、突触形成和适应性髓鞘形成。简而言之,少突胶质细胞对正常的中枢神经系统完整性、认知功能和行为至关重要。
{"title":"Physiology of oligodendroglia.","authors":"Arthur M Butt, Jianqin Niu, Chenju Yi, Alexei Verkhratsky","doi":"10.1152/physrev.00023.2025","DOIUrl":"10.1152/physrev.00023.2025","url":null,"abstract":"<p><p>Oligodendrocytes are highly specialized neural cells that produce myelin, essential for rapid electrical conduction of neural signals in the central nervous system (CNS). The emergence of oligodendrocytes and myelin was a critical step in the evolution of vertebrates and fundamental for the development of the mammalian connectome, and indispensable for miniaturization and enhanced computing power of the brain. The advance in cognitive capacity is paralleled by increasing eminence of white matter, composed of interconnected bundles of myelinated axons; white matter volume increases from 6% of the brain in shrews, considered related to the most primitive mammals, up to 50% in Homo sapiens. Myelinating oligodendrocytes together with smaller populations of oligodendrocyte precursor cells (OPCs) and satellite or perineuronal oligodendrocytes account for more than half the glial cells in the human brain. Together, these three cell types make up the oligodendroglial cell lineage that express common lineage specific proteins and transcription factors and display a degree of molecular and functional diversity. OPCs are the most numerous oligodendroglial cells during developmental axonal myelination, which extends postnatally for many years in humans. The generation of myelinating oligodendrocytes from OPCs throughout life continues to be important for adaptive plasticity of neural circuits and myelination of new axons required for learning. Myelination decreases in the aging brain and correlates with natural or physiological age-related cognitive decline. Like all neural cells, oligodendroglia express a wide assortment of ion channels, transporters, and neurotransmitter receptors that are essential for maintaining neuronal signaling, principally myelination, axonal metabolic support and homeostatic regulation of the periaxonal microenvironment. Notably, OPCs are unique amongst neuroglia in that, like neurons, they are electrically excitable and form synapses with neurons. Oligodendroglial cells also contribute to neuroplasticity through multiple mechanisms including axon guidance, synapse formation and adaptive myelination. In short, oligodendroglia are essential for normal CNS integrity, cognitive function and behavior.</p>","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":" ","pages":""},"PeriodicalIF":28.7,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147365563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuronal ensembles in cortical function and disease. 皮层功能和疾病中的神经元群。
IF 33.6 1区 医学 Q1 PHYSIOLOGY Pub Date : 2026-03-06 DOI: 10.1152/physrev.00003.2025
Rafael Yuste
Neuronal ensembles, defined as groups of coactive neurons, are physiological modules of the cerebral cortex. Calcium imaging and optogenetics have enabled mapping and manipulating ensembles with single cell resolution in mouse visual cortex, providing evidence of their importance. Ensembles dominate cortical activity, are generated endogenously or by sensory stimulation. Ensembles are imprinted by activating neurons synchronously and can be reactivated by "pattern completion" trigger cells. Intrinsic excitability mediates ensemble coactivation and reactivation, while UP states shield ongoing ensembles from external inputs. Neurons can belong to different ensembles, forming a combinatorial system that encodes visual stimuli accurately and stably. Ensembles contain pyramidal neurons and interneurons and inhibited "offsemble" cells. Cross-inhibition makes ensembles orthogonal from one another, while astrocytic activation increases ensemble occurrence. Ensembles can last for weeks, providing a substrate for long-term information storage, and they capture the recent history of stimulus presentation, implementing short-term memory. Optogenetic manipulation of ensembles demonstrates that they are necessary and sufficient for visual discrimination and perceptual states. Ensembles are altered in mouse models of epilepsy, schizophrenia, Alzheimer's disease, autism spectrum disorders and medically-induced loss of consciousness. An ensemble model of the cortex is proposed in which ensembles are functional units that activate each other via trigger cells and silence non-desired ensembles by cross-inhibition. This generates a map of orthogonal attractor states, forming a computationally powerful memory and processing system. Ensembles are likely involved in many brain diseases, so manipulating them could offer avenues for new therapeutics.
神经元群被定义为共同活动的神经元群,是大脑皮层的生理模块。钙成像和光遗传学已经能够在小鼠视觉皮层中以单细胞分辨率绘制和操纵集合,为它们的重要性提供了证据。集合控制皮层活动,由内源性或感官刺激产生。集合是通过同步激活神经元而形成的,并且可以通过“模式完成”触发细胞重新激活。固有兴奋性介导整体共激活和再激活,而UP状态保护正在进行的整体免受外部输入的影响。神经元可以属于不同的集合,形成一个精确而稳定地编码视觉刺激的组合系统。集合包括锥体神经元和中间神经元,以及抑制的“异形”细胞。交叉抑制使集合相互正交,而星形细胞激活则增加集合的发生。集合可以持续数周,为长期信息存储提供基础,它们捕捉刺激呈现的近期历史,实现短期记忆。光遗传学操作的集合表明,他们是必要的和充分的视觉辨别和知觉状态。在癫痫、精神分裂症、阿尔茨海默病、自闭症谱系障碍和药物引起的意识丧失的小鼠模型中,集合被改变。提出了一种皮质的集合模型,其中集合是通过触发细胞相互激活的功能单元,并通过交叉抑制使非期望的集合沉默。这产生了一个正交吸引子状态的映射,形成了一个计算能力强大的存储和处理系统。许多脑部疾病都可能涉及到集合,因此操纵它们可以为新的治疗方法提供途径。
{"title":"Neuronal ensembles in cortical function and disease.","authors":"Rafael Yuste","doi":"10.1152/physrev.00003.2025","DOIUrl":"https://doi.org/10.1152/physrev.00003.2025","url":null,"abstract":"Neuronal ensembles, defined as groups of coactive neurons, are physiological modules of the cerebral cortex. Calcium imaging and optogenetics have enabled mapping and manipulating ensembles with single cell resolution in mouse visual cortex, providing evidence of their importance. Ensembles dominate cortical activity, are generated endogenously or by sensory stimulation. Ensembles are imprinted by activating neurons synchronously and can be reactivated by \"pattern completion\" trigger cells. Intrinsic excitability mediates ensemble coactivation and reactivation, while UP states shield ongoing ensembles from external inputs. Neurons can belong to different ensembles, forming a combinatorial system that encodes visual stimuli accurately and stably. Ensembles contain pyramidal neurons and interneurons and inhibited \"offsemble\" cells. Cross-inhibition makes ensembles orthogonal from one another, while astrocytic activation increases ensemble occurrence. Ensembles can last for weeks, providing a substrate for long-term information storage, and they capture the recent history of stimulus presentation, implementing short-term memory. Optogenetic manipulation of ensembles demonstrates that they are necessary and sufficient for visual discrimination and perceptual states. Ensembles are altered in mouse models of epilepsy, schizophrenia, Alzheimer's disease, autism spectrum disorders and medically-induced loss of consciousness. An ensemble model of the cortex is proposed in which ensembles are functional units that activate each other via trigger cells and silence non-desired ensembles by cross-inhibition. This generates a map of orthogonal attractor states, forming a computationally powerful memory and processing system. Ensembles are likely involved in many brain diseases, so manipulating them could offer avenues for new therapeutics.","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":"70 1","pages":""},"PeriodicalIF":33.6,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147359403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fueling the Fire: Metabolic Dysfunction and Senescence as Drivers of Lung Aging and Disease. 火上浇油:代谢功能障碍和衰老是肺部衰老和疾病的驱动因素。
IF 33.6 1区 医学 Q1 PHYSIOLOGY Pub Date : 2026-03-06 DOI: 10.1152/physrev.00024.2025
Corrine R Kliment,Aditi U Gurkar,Nayra Cárdenes,Richard Ramonell,Toren Finkel,Melanie Königshoff
With a rapidly expanding human population at advanced ages and age as the main driver for chronic diseases, we face the challenge of understanding tissue aging and devising new therapeutic interventions. Cellular senescence is an important hallmark of all aging tissues and has emerged as a potential key driver of chronic lung diseases, including pulmonary fibrosis, chronic obstructive pulmonary disease (COPD), and asthma. This comprehensive review recapitulates current knowledge of pathways and processes involved in cellular senescence with emphasis on the role of mitochondrial dysfunction and the "4 Ms" (morphology, mitophagy, metabolism, and metabolites). We review our current knowledge of healthy lung aging, discuss which pathomechanisms in chronic lung disease are characterized by senescence, and summarize current target therapeutics and their impact on lung disease. Within this exponentially growing field, we propose emerging concepts and current gaps in knowledge which need to be addressed to develop better opportunities for therapeutic strategies and future investigations.
随着老年人口的快速增长和老年人口成为慢性疾病的主要驱动因素,我们面临着理解组织衰老和设计新的治疗干预措施的挑战。细胞衰老是所有衰老组织的重要标志,并已成为慢性肺部疾病(包括肺纤维化、慢性阻塞性肺疾病(COPD)和哮喘)的潜在关键驱动因素。这篇全面的综述概述了目前关于细胞衰老的途径和过程的知识,重点是线粒体功能障碍和“4ms”(形态学、线粒体自噬、代谢和代谢物)的作用。我们回顾了我们目前对健康肺部衰老的认识,讨论了慢性肺部疾病的哪些病理机制以衰老为特征,并总结了目前的靶向治疗方法及其对肺部疾病的影响。在这个指数级增长的领域,我们提出了新兴的概念和目前的知识差距,需要解决这些问题,以开发更好的治疗策略和未来的研究机会。
{"title":"Fueling the Fire: Metabolic Dysfunction and Senescence as Drivers of Lung Aging and Disease.","authors":"Corrine R Kliment,Aditi U Gurkar,Nayra Cárdenes,Richard Ramonell,Toren Finkel,Melanie Königshoff","doi":"10.1152/physrev.00024.2025","DOIUrl":"https://doi.org/10.1152/physrev.00024.2025","url":null,"abstract":"With a rapidly expanding human population at advanced ages and age as the main driver for chronic diseases, we face the challenge of understanding tissue aging and devising new therapeutic interventions. Cellular senescence is an important hallmark of all aging tissues and has emerged as a potential key driver of chronic lung diseases, including pulmonary fibrosis, chronic obstructive pulmonary disease (COPD), and asthma. This comprehensive review recapitulates current knowledge of pathways and processes involved in cellular senescence with emphasis on the role of mitochondrial dysfunction and the \"4 Ms\" (morphology, mitophagy, metabolism, and metabolites). We review our current knowledge of healthy lung aging, discuss which pathomechanisms in chronic lung disease are characterized by senescence, and summarize current target therapeutics and their impact on lung disease. Within this exponentially growing field, we propose emerging concepts and current gaps in knowledge which need to be addressed to develop better opportunities for therapeutic strategies and future investigations.","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":"3 1","pages":""},"PeriodicalIF":33.6,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147359402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epithelial plasma membrane transporters as drug targets 上皮质膜转运蛋白作为药物靶点
IF 33.6 1区 医学 Q1 PHYSIOLOGY Pub Date : 2026-03-04 DOI: 10.1152/physrev.00045.2025
Alan S. Verkman
Physiological Reviews, Ahead of Print.
《生理评论》,出版前。
{"title":"Epithelial plasma membrane transporters as drug targets","authors":"Alan S. Verkman","doi":"10.1152/physrev.00045.2025","DOIUrl":"https://doi.org/10.1152/physrev.00045.2025","url":null,"abstract":"Physiological Reviews, Ahead of Print. <br/>","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":"93 1","pages":""},"PeriodicalIF":33.6,"publicationDate":"2026-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147351030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stomach at the Crossroads: Nuclear Receptor Signaling at the Interface Between What We Are and What We Eat. 十字路口的胃:我们是什么和我们吃什么之间的接口的核受体信号。
IF 28.7 1区 医学 Q1 PHYSIOLOGY Pub Date : 2026-02-24 DOI: 10.1152/physrev.00033.2025
Margarita Divenko, Jason C Mills

The stomach is home to numerous nuclear receptor transcription factors (NRs) that can respond to food, toxins, and other ingested agents. Conversely, signals secreted from other organs (e.g., hormones) can engage gastric NRs to modulate gastric physiology. Thus, there is a rich potential interface between external and internal signals that gastric NRs might respond to and interpret. Here, we seek to comprehensively review the role of NRs in gastric homeostasis and disease pathogenesis. NRs are evolutionarily conserved proteins that regulate gene transcription by interpreting hormonal and environmental signals. We explore NR roles in normal stomach development, cell fate determination, and responses to dietary compounds and xenobiotics. The last topic is of particular recent importance, because: 1) NRs stimulated by ingested agents might directly regulate gastric physiology like the relative activity of acid-secreting and stem cells; and 2) because the stomach is one of the first organs to encounter dietary compounds and pollutants. Additionally, we will review emerging yet understudied field of gastro-endocrinology, exploring how systemic endocrine circuits influence the stomach's function. We also discuss how NRs contribute to pathological conditions like precancerous lesions and cancer. Additionally, we summarize known agonists, antagonists, and co-regulatory proteins, highlighting potential therapeutic targets. Understanding NR roles could pave the way for a better understanding of dietary and environmental toxin exposure and also lead to innovative treatments for gastric disorders, including gastritis, gastric intestinal metaplasia, and gastric cancer.

胃是许多核受体转录因子(NRs)的家园,它们可以对食物、毒素和其他摄入的物质做出反应。相反,其他器官(如激素)分泌的信号可以参与胃NRs调节胃生理。因此,在外部和内部信号之间存在丰富的潜在接口,胃NRs可能对这些信号作出反应和解释。在这里,我们试图全面回顾NRs在胃内稳态和疾病发病机制中的作用。NRs是进化上保守的蛋白质,通过解释激素和环境信号来调节基因转录。我们探讨NR在正常胃发育、细胞命运决定以及对膳食化合物和外源药物的反应中的作用。最后一个主题是最近特别重要的,因为:1)摄取药物刺激的NRs可能直接调节胃生理,如分泌酸和干细胞的相对活性;2)因为胃是最先接触到膳食化合物和污染物的器官之一。此外,我们将回顾新兴但尚未充分研究的胃内分泌学领域,探讨系统内分泌回路如何影响胃的功能。我们还讨论了NRs如何导致癌前病变和癌症等病理状况。此外,我们总结了已知的激动剂、拮抗剂和共调节蛋白,突出了潜在的治疗靶点。了解NR的作用可以为更好地理解饮食和环境毒素暴露铺平道路,也可以为胃炎、胃肠道化生和胃癌等胃疾病提供创新的治疗方法。
{"title":"Stomach at the Crossroads: Nuclear Receptor Signaling at the Interface Between What We Are and What We Eat.","authors":"Margarita Divenko, Jason C Mills","doi":"10.1152/physrev.00033.2025","DOIUrl":"https://doi.org/10.1152/physrev.00033.2025","url":null,"abstract":"<p><p>The stomach is home to numerous nuclear receptor transcription factors (NRs) that can respond to food, toxins, and other ingested agents. Conversely, signals secreted from other organs (e.g., hormones) can engage gastric NRs to modulate gastric physiology. Thus, there is a rich potential interface between external and internal signals that gastric NRs might respond to and interpret. Here, we seek to comprehensively review the role of NRs in gastric homeostasis and disease pathogenesis. NRs are evolutionarily conserved proteins that regulate gene transcription by interpreting hormonal and environmental signals. We explore NR roles in normal stomach development, cell fate determination, and responses to dietary compounds and xenobiotics. The last topic is of particular recent importance, because: 1) NRs stimulated by ingested agents might directly regulate gastric physiology like the relative activity of acid-secreting and stem cells; and 2) because the stomach is one of the first organs to encounter dietary compounds and pollutants. Additionally, we will review emerging yet understudied field of gastro-endocrinology, exploring how systemic endocrine circuits influence the stomach's function. We also discuss how NRs contribute to pathological conditions like precancerous lesions and cancer. Additionally, we summarize known agonists, antagonists, and co-regulatory proteins, highlighting potential therapeutic targets. Understanding NR roles could pave the way for a better understanding of dietary and environmental toxin exposure and also lead to innovative treatments for gastric disorders, including gastritis, gastric intestinal metaplasia, and gastric cancer.</p>","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":" ","pages":""},"PeriodicalIF":28.7,"publicationDate":"2026-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147276782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular Systems, Human Non-Coding Sequence Variants, and Blood Pressure. 分子系统,人类非编码序列变异和血压。
IF 33.6 1区 医学 Q1 PHYSIOLOGY Pub Date : 2026-01-30 DOI: 10.1152/physrev.00029.2025
Qiongzi Qiu,Mingyu Liang
The human genome harbors millions of non-coding sequence variants. Genome-wide association studies (GWAS) have identified thousands of robust associations linking non-coding variants to human physiological traits and complex diseases. Integrative approaches, including expression quantitative trait locus mapping, epigenomic profiling, and precise genome editing in trait-relevant cell types, enable the identification of effector genes and underlying regulatory mechanisms, such as long-range chromatin interactions, that mediate the effects of non-coding variants. Investigations of blood pressure (BP)-associated non-coding sequence variants have uncovered previously unrecognized roles of genes in BP regulation, reinforced the human genetic relevance of established BP regulatory pathways, and elucidated specific regulatory mechanisms by which non-coding variants influence gene expression and BP. Studies of orthologous non-coding genomic regions in animal models corresponding to human genomic regions harboring BP-associated variants have demonstrated substantial effects on BP, suggesting that the phenotypic impact of non-coding sequence variants may be large within human subgroups. Continued expansion of functional studies of trait-associated non-coding sequence variants, together with advances in mapping molecular quantitative trait loci and epigenomic landscapes, will provide novel insights directly relevant to human biology and disease and essential for understanding humans as molecular systems.
人类基因组包含数百万个非编码序列变体。全基因组关联研究(GWAS)已经确定了数千种将非编码变异与人类生理特征和复杂疾病联系起来的强大关联。综合方法,包括表达数量性状位点定位、表观基因组谱分析和性状相关细胞类型的精确基因组编辑,能够识别介导非编码变异影响的效应基因和潜在的调节机制,如远程染色质相互作用。对血压(BP)相关非编码序列变异的研究揭示了先前未被认识到的基因在BP调控中的作用,加强了已建立的BP调控途径的人类遗传相关性,并阐明了非编码变异影响基因表达和BP的特定调控机制。在动物模型中对含有BP相关变异的人类基因组区域对应的同源非编码基因组区域的研究表明,非编码序列变异对BP有实质性影响,这表明非编码序列变异对人类亚群的表型影响可能很大。性状相关的非编码序列变异的功能研究的持续扩展,以及分子定量性状位点和表观基因组图谱的进展,将提供与人类生物学和疾病直接相关的新见解,对理解人类作为分子系统至关重要。
{"title":"Molecular Systems, Human Non-Coding Sequence Variants, and Blood Pressure.","authors":"Qiongzi Qiu,Mingyu Liang","doi":"10.1152/physrev.00029.2025","DOIUrl":"https://doi.org/10.1152/physrev.00029.2025","url":null,"abstract":"The human genome harbors millions of non-coding sequence variants. Genome-wide association studies (GWAS) have identified thousands of robust associations linking non-coding variants to human physiological traits and complex diseases. Integrative approaches, including expression quantitative trait locus mapping, epigenomic profiling, and precise genome editing in trait-relevant cell types, enable the identification of effector genes and underlying regulatory mechanisms, such as long-range chromatin interactions, that mediate the effects of non-coding variants. Investigations of blood pressure (BP)-associated non-coding sequence variants have uncovered previously unrecognized roles of genes in BP regulation, reinforced the human genetic relevance of established BP regulatory pathways, and elucidated specific regulatory mechanisms by which non-coding variants influence gene expression and BP. Studies of orthologous non-coding genomic regions in animal models corresponding to human genomic regions harboring BP-associated variants have demonstrated substantial effects on BP, suggesting that the phenotypic impact of non-coding sequence variants may be large within human subgroups. Continued expansion of functional studies of trait-associated non-coding sequence variants, together with advances in mapping molecular quantitative trait loci and epigenomic landscapes, will provide novel insights directly relevant to human biology and disease and essential for understanding humans as molecular systems.","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":"82 1","pages":""},"PeriodicalIF":33.6,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146088909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Physiological reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1